Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment

The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD management.

EP: 1.Tackling Key Concerns in Atopic Dermatitis + Biologic Use

EP: 2.Atopic Dermatitis: Topical Therapies and Unmet Needs in the Treatment Landscape

Now Viewing

EP: 3.Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment

EP: 4.Experts Discuss Long-Term Effects and Monitoring in AD Therapy

EP: 5.Balancing Safety and Efficacy: Optimizing Topical Treatment Options for AD

EP: 6.The Patient Journey: Effectively Managing AD Itch Early On

EP: 7.Streamlining Prior Authorization for Topical AD Therapies: Expert Strategies

EP: 8.Experts Share Final Insights to Optimize Atopic Dermatitis Patient Care

1. Based on your experience, how have topical treatments evolved beyond the use of topical steroids and topical calcineurin inhibitors?
2. When it comes to topical ruxolitinib, how do you balance the efficacy versus the safety when deciding to treat patients with it?

Related Videos

Related Content

Advertisement

November 22nd 2024

Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer

Brooke McCormick

Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, highlighting the need for earlier interventions.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 21st 2024

Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link

Kimberly Rath, PharmD

A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.

July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.

November 20th 2024

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

Ryan Flinn Mary Caffrey

Related Content

Advertisement

November 22nd 2024

Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer

Brooke McCormick

Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, highlighting the need for earlier interventions.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 21st 2024

Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link

Kimberly Rath, PharmD

A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.

July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.

November 20th 2024

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

Ryan Flinn Mary Caffrey